Completed
Effects of Whole-Body Electromyostimulation (WB-EMS) Combined With Individualized Nutritional Support on Patients With Malignant Disease Undergoing Curative or Palliative Anti-cancer Treatment
What is being tested
Whole-Body Electromyostimulation (WB-EMS)
Other
Who is being recruted
Atrophy+15
+ Body Weight
+ Body Weight Changes
Over 18 Years
+11 Eligibility Criteria
How is the trial designed
Treatment Study
Interventional
Study Start: August 2013
Summary
Principal SponsorUniversity of Erlangen-Nürnberg Medical School
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: August 1, 2013
Actual date on which the first participant was enrolled.This study evaluates the effects of a 12-week whole-body electromyostimulation (WB-EMS) training combined with individualized nutritional support on body composition, muscle strength and function and quality of life of patients with malignant disease undergoing curative or palliative anti-cancer treatment
Official TitleEffects of Whole-Body Electromyostimulation (WB-EMS) Combined With Individualized Nutritional Support on Patients With Malignant Disease Undergoing Curative or Palliative Anti-cancer Treatment
Principal SponsorUniversity of Erlangen-Nürnberg Medical School
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
278 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
AtrophyBody WeightBody Weight ChangesCachexiaMuscular AtrophyMuscular DiseasesMusculoskeletal DiseasesNeoplasmsNervous System DiseasesNeurologic ManifestationsPathologic ProcessesSigns and SymptomsPathological Conditions, Signs and SymptomsThinnessWeight LossMuscle WeaknessPathological Conditions, AnatomicalNeuromuscular Manifestations
Criteria
2 inclusion criteria required to participate
malignant disease (solid or hematological cancer): head and neck cancer, colorectal carcinoma, small intestinal cancer, gastric cancer, oesophageal cancer, pancreas carcinoma, liver cell carcinoma, cholangiocarcinoma,lung cancer, breast cancer, cervix cancer, ovarian cancer, prostate cancer, renal cell carcinoma, malignant melanoma, patients with leukaemia and malignant lymphomas or Graft-versus-Host-Disease after bone marrow transplantation
ongoing or planned curative or palliative anti-cancer therapy
9 exclusion criteria prevent from participating
simultaneous participation in other nutritional or exercise intervention trials
acute cardiovascular events
use of anabolic medications
epilepsy
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Experimentalphysical exercise group regular WB-EMS training (2 EMS trainings per week; each session for 20 min)
\+ individualized nutritional support (dietary advices: daily protein intake \> 1.0 g/kg bodyweight)
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
Medizinische Klinik 1, University of Erlangen-Nürnberg
Erlangen, GermanyOpen Medizinische Klinik 1, University of Erlangen-Nürnberg in Google MapsCompletedOne Study Center